FindTrial
Sign In

A retrospective study on the protocol and evaluation of the combination of Chinese and Western medicine for the prevention and treatment of amyotrophic lateral sclerosis/motor neuron disease

A protocol and evaluation study on the combination of Chinese and Western medicine for the prevention and treatment of amyotrophic lateral sclerosis/motor neuron disease—a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068590
Enrollment
Unknown
Registered
2023-02-24
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motor neuron disease/Amyotrophic Lateral Sclerosis

Interventions

Group 1:no

Sponsors

Hubei Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Conform to the Western Medicine 2020 Gold Coast diagnostic criteria and confirmed, probable, and suspicious diagnoses; 2. Type is not limited; 3. Phase 1-4; 4. Severity level I-IV; 5. FVC >= 50%; 6. Age between 18-80; 7. Patients with complete and accurate clinical medical records.

Exclusion criteria

Exclusion criteria: 1. Those with incomplete medical records; 2. Unable to cooperate with the researcher; 3. Wrongly included.

Design outcomes

Primary

MeasureTime frame
ALSFRS-R score;MRC muscle strength classification;—

Secondary

MeasureTime frame
Demographic information;Clinical Information;Main laboratory indicators;—

Countries

China

Contacts

Public ContactChen Gang

Hubei Hospital of Traditional Chinese Medicine

250149875@qq.com+86 135 4517 4473

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026